Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ecdhCfbwoceVotxdjvjP

December 11, 2012
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
 
  • Philippines unveils 1st isotope generator facility
    The Philippine Nuclear Research Institute has launched the country's first molybdenum-99/technetium-99m generator production facility. PNRI Director Alumanda dela Rosa said the facility could allow for a 50% reduction in patient costs for tests with technetium-99m. The facility should be able to provide hospitals with lower-cost radioisotopes by February. Philippine Daily Inquirer (12/11) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
How can we help with your radiation reduction initiatives?
The MEDRAD™ Intego™ has helped PET sites across the world reduce unnecessary radiation exposure. Utilizing a fully shielded, mobile design, the system infuses doses-on-demand from a multi-dose vial, providing added protection and more accurate, repeatable, patient-specific dosing. See more here.
  Clinical News & Research 
  • Combined tests provide most data for Alzheimer's diagnosis
    Combining MRI, FDG-PET and cerebrospinal fluid analysis provided the most data for diagnosing Alzheimer's disease and allowed researchers to achieve the lowest misclassification rate of 28.4% when compared with neuropsychological testing, according to a study by Duke Medicine researchers. They also observed that of the three methods, FDG-PET provided the most data for use in diagnosing early Alzheimer's in people with mild cognitive impairment. More studies are needed to further understand the use of the tests in the clinical environment, researchers said. MedicalXpress.com/News release (12/11) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • Absolute Imaging to distribute Mediso SPECT cameras in U.S.
    Absolute Imaging Solutions has entered into a five-year deal with Hungarian company Mediso Medical Imaging Systems involving the distribution of SPECT systems. Absolute Imaging will be the exclusive U.S. distributor of Mediso's Nucline CardioDesk dual-head cardiac SPECT camera and the AnyScan S single-head and dual-head general-purpose SPECT cameras. AuntMinnie.com (free registration) (12/10) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Report: Use of health care apps still lags
    The adoption of health care applications still lags despite the contributions of devices such as smartphones to patients' care, according to a report by the Bipartisan Policy Center. The report found obstacles include consumers' low awareness about apps and the need for further innovation in creating apps. Healthcare IT News (12/10) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • Senators urge device tax implementation delay amid repeal efforts
    A group of senators asked Senate Majority Leader Harry Reid, D-Nev., to defer the start of the 2.3% medical device tax as efforts to repeal the levy continue. In a letter, the group urged Reid to support efforts to make sure the U.S. "maintains its global leadership position in the medical technology industry and keeps good jobs here at home." MassDevice.com (Boston) (12/10) LinkedInFacebookTwitterEmail this Story
  • Opinion: FDA demands drive up drug development costs
    The FDA's consistent demands for more tests and bigger clinical trials are driving increased costs for pharmaceutical research and development, according to this opinion piece. The FDA isn't responsible for making sure drug companies make profits, and neither should it be pushing innovation toward financial impossibility, the writers argue. The Examiner (Washington, D.C.) (12/6) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Planned British DNA database could boost drug R&D
    The British government has allotted $160 million to create a genome database of as many as 100,000 patients with cancer and rare conditions over the next three to five years. The project could change the way complex illnesses are diagnosed and treated as well as enhance the discovery and development of novel drugs, Prime Minister David Cameron said. Reuters (12/10) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
  From SNMMI 
  • Renew your SNMMI membership for 2013!
    Renew your membership today and continue to take advantage of SNMMI's extensive member benefits, including the world's No. 1 medical imaging journal — The Journal of Nuclear Medicine — along with continuing education opportunities and great member discounts. Renew today. LinkedInFacebookTwitterEmail this Story
  • Robert E. Henkin Government Relations Fellowship submission deadline is Dec. 31
    Submit your application for the Robert E. Henkin Government Relations Fellowship. Nuclear medicine is a highly regulated profession, and it is essential for its leaders to have firsthand understanding of regulatory challenges. This fellowship will provide gifted, highly motivated young nuclear and molecular imaging professionals with firsthand experience in the process of health policy development. Application deadline is Dec. 31. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
Put a grain of boldness into everything you do."
--Baltasar Gracián,
Spanish writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.®  Legal Information